Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Xos Inc.

Start price
Target price
Perf. (%)
€1.05
03.10.22
€1.00
03.10.23
2.86%
15.10.22

Could be very worthwhile Investment >20% year
Very capable Management
Very good company culture
Few uniques
buy
Covetrus Inc.

Start price
Target price
Perf. (%)
€17.14
19.09.21
€20.00
19.09.22
18.26%
20.09.22

Could be worthwhile Investment >10% per year
buy
Neoen S.a.

Start price
Target price
Perf. (%)
€33.20
16.09.21
€35.00
16.09.22
18.77%
17.09.22

Could be worthwhile Investment >10% per year
buy
Kuka AG

Start price
Target price
Perf. (%)
€67.00
05.09.21
€77.00
05.09.22
21.64%
06.09.22

Revenue growth >5% per year expected
Market Leader or Top 3
Rising EBIT margin expected
Very Future proof/growth oriented business model
Geovax Labs Inc.

Start price
Target price
Perf. (%)
€3.24
07.08.22
€2.00
07.08.23
-48.72%
22.08.22

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Higher EBIT margin than peer group
EBIT decline/stagnation expected
buy
Genetic Technologies Ltd.

Start price
Target price
Perf. (%)
€1.37
16.07.22
€1.00
16.07.23
0.73%
02.08.22

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
High valuation
Very low/no dividend yield expected
buy
11 Bit Studios Sa

Start price
Target price
Perf. (%)
€90.25
26.09.21
€95.00
26.09.22
16.34%
10.07.22

Could be worthwhile Investment >10% per year
buy
Cairn Energy Plc

Start price
Target price
Perf. (%)
€3.38
30.06.21
€4.00
30.06.22
43.20%
01.07.22

Could be worthwhile Investment >10% per year
Dufry AG

Start price
Target price
Perf. (%)
€3.84
27.11.21
€3.50
01.04.23
-20.83%
29.06.22

Could be worthwhile Investment >10% per year
Igm Biosciences Inc.

Start price
Target price
Perf. (%)
€25.40
14.12.21
€35.00
31.12.23
-30.71%
28.06.22

Could be very worthwhile Investment >20% year
Odonate Therapeutics Inc.

Start price
Target price
Perf. (%)
€1.44
01.12.21
€1.00
31.12.23
-3.47%
28.06.22

Could be very worthwhile Investment >20% year
Ocugen Inc.

Start price
Target price
Perf. (%)
€5.62
01.12.21
€4.00
31.12.23
-59.47%
28.06.22

Could be very worthwhile Investment >20% year
Anterix Inc.

Start price
Target price
Perf. (%)
€52.50
24.06.21
€48.00
24.06.22
-26.10%
25.06.22

Could be worthwhile Investment >10% per year
buy
Clabo S.p.a.

Start price
Target price
Perf. (%)
€1.73
06.06.21
€2.00
06.06.22
46.24%
07.06.22

Could be worthwhile Investment >10% per year
buy
Oriola Oyj

Start price
Target price
Perf. (%)
€1.80
30.05.21
€2.00
30.05.22
16.67%
31.05.22

Could be worthwhile Investment >10% per year
buy
Alfen

Start price
Target price
Perf. (%)
€67.90
26.05.21
€79.00
26.05.22
45.07%
27.05.22

buy
Superior Drilling Products Inc

Start price
Target price
Perf. (%)
€0.63
23.05.21
€0.66
23.05.22
45.27%
24.05.22

Could be worthwhile Investment >10% per year
buy
Cwc Energy Services Corp.

Start price
Target price
Perf. (%)
€0.085
01.05.21
€0.12
01.05.22
147.06%
02.05.22

Could be worthwhile Investment >10% per year
Revenio Group Corp.

Start price
Target price
Perf. (%)
€59.55
29.04.21
€56.00
29.04.22
-25.07%
30.04.22

Could be worthwhile Investment >10% per year
buy
Arch Resources Inc.

Start price
Target price
Perf. (%)
€34.40
25.03.21
€38.00
25.03.22
277.91%
26.03.22

Could be worthwhile Investment >10% per year
buy
Beyond Air Inc.

Start price
Target price
Perf. (%)
€4.56
24.03.21
€6.00
24.03.22
32.89%
25.03.22

Could be worthwhile Investment >10% per year
Brii Biosciences Ltd.

Start price
Target price
Perf. (%)
€3.10
08.01.22
€2.00
08.01.23
-37.74%
28.01.22

Could be worthwhile Investment >10% per year
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
Everfuel A/S

Start price
Target price
Perf. (%)
€14.04
13.01.21
€6.00
13.01.22
-68.83%
14.01.22

Very Future proof/growth oriented business model
Probably not worthwhile Investment
Very low/no dividend yield expected
Nicheplayer
Surface Oncology Inc.

Start price
Target price
Perf. (%)
€6.37
20.09.21
€5.00
20.09.22
-29.23%
05.12.21

Could be worthwhile Investment >10% per year
Very low/no dividend yield expected
Risky balance sheet
Ocugen Inc.

Start price
Target price
Perf. (%)
€8.07
09.11.21
€6.00
09.11.22
-30.32%
01.12.21

Could be very worthwhile Investment >20% year